Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain

Free Radical Biology and Medicine

Volumn 33, Issue 9, 2002, Pages 1194-1199

  Smith, Mark A ^a   Casadesus, Gemma ^b   Joseph, James A ^b   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Amyloid ; Antioxidant; Free radical; Phosphorylation; Redox active metals; Tau

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENILE PLAQUE;

EID: 0036829434     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01021-3     Document Type: Article

References (57)

1. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
2. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
3. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein a reanalysis of a therapeutic hypothesis . J. Alzheimer's Dis. 3:2001;75-81.
4. Knowles R.B., Gomez-Isla T., Hyman B.T. Aβ associated neuropil changes correlation with neuronal loss and dementia . J. Neuropathol. Exp. Neurol. 57:1998;1122-1130.
5. Selkoe D.J. Alzheimer's disease genotypes, phenotypes, and treatments . Science. 275:1997;630-631.
6. Smith M.A., Joseph J.A., Perry G. Arson tracking the culprit in Alzheimer's disease . Ann. NY Acad. Sci. 924:2000;35-38.
7. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59:2000;1011-1017.
8. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
9. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P. Non-enzymatically glycated τ in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1:1995;693-699.
10. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.I. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275:2000;19439-19442.
11. Davis D.G., Schmitt F.A., Wekstein D.R., Markesbery W.R. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol. 58:1999;376-388.
12. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:1991;367-368.
13. Davies L., Wolska B., Hilbich C., Multhaup G., Martins R., Simms G., Beyreuther K., Masters C.L. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques . Neurology. 38:1988;1688-1693.
14. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866.
15. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M.B., Teplow D.B., Haass C., Seubert P., Koo E.H., Selkoe D.J. Enhanced production and oligomerization of the 42-residue amyloid beta- protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:1997;7977-7982.
16. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
17. Joseph J.A., Shukitt-Hale B., Denisova N.A., Prior R.L., Cao G., Martin A., Taglialatela G., Bickford P.C. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J. Neurosci. 18:1998;8047-8055.
18. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., Bickford P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 19:1999;8114-8121.
19. Bickford P.C., Gould T., Briederick L., Chadman K., Pollock A., Young D., Shukitt-Hale B., Joseph J. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 866:2000;211-217.
20. Takeda A., Perry G., Abraham N.G., Dwyer B.E., Kutty R.K., Laitinen J.T., Petersen R.B., Smith M.A. Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J. Biol. Chem. 275:2000;5395-5399.
21. Long J.M., Mouton P.R., Jucker M., Ingram D.K. What counts in brain aging? Design-based stereological analysis of cell number. J. Gerontol. A Biol. Sci. Med. Sci. 54:1999;B407-B417.
22. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
23. Pappolla M.A., Chyan Y.-J., Omar R.A., Hsiao K., Perry G., Smith M.A., Bozner P. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease a chronic oxidative paradigm for testing antioxidant therapies in vivo . Am. J. Pathol. 152:1998;871-877.
24. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
25. Praticó D., Uryu U., Leight S., Trojanowski J.Q., Lee V.M.-Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21:2001;4183-4187.
26. Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994;42-47.
27. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science. 235:1987;1641-1644.
28. Perry G., Friedman R., Shaw G., Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. USA. 84:1987;3033-3036.
29. Rottkamp C.A., Raina A.K., Zhu X., Gaier E., Bush A.I., Atwood C.S., Chevion M., Perry G., Smith M.A. Redox-active iron mediates amyloid-β toxicity. Free Radic. Biol. Med. 30:2001;447-450.
30. Frautschy S.A., Cole G.M., Baird A. Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am. J. Pathol. 140:1992;1389-1399.
31. Canning D.R., McKeon R.J., DeWitt D.A., Perry G., Wujek J.R., Frederickson R.C.A., Silver J. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:1993;289-298.
32. DeWitt D.A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149:1998;329-340.
33. Butterfield D.A., Yatin S.M., Link C.D. In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide (1-42). Ann. NY Acad. Sci. 893:1999;265-268.
34. Butterfield D.A., Yatin S.M., Varadarajan S., Koppal T. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease. Methods Enzymol. 309:1999;746-768.
35. Walter M.F., Mason P.E., Mason R.P. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions. Biochem. Biophys. Res. Commun. 233:1997;760-764.
36. Calhoun M.E., Wiederhold K.H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C., Staufenbiel M., Sommer B., Jucker M. Neuron loss in APP transgenic mice. Nature. 395:1998;755-756.
37. Joseph J., Shukitt-Hale B., Denisova N.A., Martin A., Perry G., Smith M.A. Copernicus revisted amyloid beta in Alzheimer's disease . Neurobiol. Aging. 22:2001;131-146.
38. Gordon M.N., King D.L., Diamond D.M., Jantzen P.T., Boyett K.V., Hope C.E., Hatcher J.M., DiCarlo G., Gottschall W.P., Morgan D., Arendash G.W. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice. Neurobiol. Aging. 22:2001;377-385.
39. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24.
40. Kril J.J., Patel S., Harding A.J., Halliday G.M. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol. (Berl.). 103:2002;370-376.
41. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964.
42. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:1995;2660-2666.
43. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
44. Takeda A., Smith M.A., Avilá J., Nunomura A., Siedlak S.L., Zhu X., Perry G., Sayre L.M. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75:2000;1234-1241.
45. Calingasan N.Y., Uchida K., Gibson G.E. Protein-bound acrolein a novel marker of oxidative stress in Alzheimer's disease . J. Neurochem. 72:1999;751-756.
46. Morsch R., Simon W., Coleman P.D. Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58:1999;188-197.
47. Wataya T., Nunomura A., Smith M.A., Siedlak S.L., Harris P.L.R., Shimohama S., Szweda L.I., Kaminski M.A., Avila J., Price D.L., Cleveland D.W., Sayre L.M., Perry G. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277:2002;4644-4648.
48. Zhu X., Rottkamp C.A., Boux H., Takeda A., Perry G., Smith M.A. Activation of p38 kinase links τ phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:2000;880-888.
49. Zhu X., Castellani R.J., Takeda A., Nunomura A., Atwood C.S., Perry G., Smith M.A. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease the "two hit" hypothesis . Mech. Ageing Dev. 123:2001;39-46.
50. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., Smith M.A. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76:2001;435-441.
51. Zhu X., Rottkamp C.A., Hartzler A., Sun Z., Takeda A., Boux H., Shimohama S., Perry G., Smith M.A. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J. Neurochem. 79:2001;311-318.
52. Odetti P., Garibaldi S., Norese R., Angelini G., Marinelli L., Valentini S., Menini S., Traverso N., Zaccheo D., Siedlak S., Perry G., Smith M.A., Tabaton M. Lipoperoxidation is selectively involved in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 59:2000;393-397.
53. Gerst J.L., Siedlak S.L., Nunomura A., Castellani R., Perry G., Smith M.A. Role of oxidative stress in frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 10:(Suppl. 1):1999;85-87.
54. Ekinci F.J., Shea T.B. Phosphorylation of τ alters its association with the plasma membrane. Cell. Mol. Neurobiol. 20:2000;497-508.
55. Perry G., Nunomura A., Raina A.K., Smith M.A. Amyloid-β junkies. Lancet. 355:2000;757.
56. Smith M.A., Atwood C.S., Joseph J.A., Perry G. Predicting the failure of the amyloid-β vaccine. Lancet. 359:2002;1864-1865.
57. Rottkamp C.A., Atwood C.S., Joseph J.A., Nunomura A., Perry G., Smith M.A. The state versus amyloid-β the trial of the most wanted criminal in Alzheimer disease . Peptides. 23:2002;1333-1341.